Deutsche Bank AG Trims Stock Position in Cencora, Inc. $COR

Deutsche Bank AG cut its stake in Cencora, Inc. (NYSE:COR) by 20.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 920,782 shares of the company’s stock after selling 232,362 shares during the quarter. Deutsche Bank AG’s holdings in Cencora were worth $310,994,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Cencora by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 23,617,117 shares of the company’s stock valued at $7,976,681,000 after acquiring an additional 221,570 shares during the last quarter. State Street Corp lifted its position in Cencora by 9.3% in the third quarter. State Street Corp now owns 9,190,316 shares of the company’s stock valued at $2,872,249,000 after acquiring an additional 782,911 shares during the last quarter. Geode Capital Management LLC lifted its position in Cencora by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 5,459,476 shares of the company’s stock valued at $1,843,268,000 after acquiring an additional 169,055 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Cencora by 6.5% in the fourth quarter. JPMorgan Chase & Co. now owns 4,982,557 shares of the company’s stock valued at $1,682,859,000 after acquiring an additional 304,760 shares during the last quarter. Finally, Boston Partners lifted its position in Cencora by 2.0% in the third quarter. Boston Partners now owns 4,509,165 shares of the company’s stock valued at $1,409,152,000 after acquiring an additional 89,506 shares during the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

Cencora Trading Up 0.7%

NYSE COR opened at $281.48 on Thursday. The stock has a market capitalization of $54.76 billion, a P/E ratio of 21.59, a P/E/G ratio of 1.51 and a beta of 0.59. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The firm has a 50-day moving average price of $290.59 and a 200 day moving average price of $328.55. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same period in the prior year, the company earned $4.42 earnings per share. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities research analysts expect that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora announced that its board has initiated a share buyback plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

Analyst Ratings Changes

A number of brokerages recently weighed in on COR. UBS Group boosted their price target on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Barclays reduced their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday. William Blair assumed coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Wells Fargo & Company reduced their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.